Browse > Article

Radiation-induced Pulmonary Toxicity following Adjuvant Radiotherapy for Breast Cancer  

Moon, Sung-Ho (Departments of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Kim, Tae-Jung (Departments of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Eom, Keun-Young (Departments of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Kim, Jee-Hyun (Departments of Breast Care Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Kim, Sung-Won (Departments of Breast Care Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Kim, Jae-Sung (Departments of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Kim, In-Ah (Departments of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
Publication Information
Radiation Oncology Journal / v.25, no.2, 2007 , pp. 109-117 More about this Journal
Abstract
[ $\underline{Purpose}$ ]: To evaluate the incidences and potential predictive factors for symptomatic radiation pneumonitis (SRP) and radiographic pulmonary toxicity (RPT) following adjuvant radiotherapy (RT) for patients with breast cancer. A particular focus was made to correlate RPT with the dose volume histogram (DVH) parameters based on three-dimensional RT planning (3D-RTP) data. $\underline{Materials\;and\;Methods}$: From September 2003 through February 2006, 171 patients with breast cancer were treated with adjuvant RT following breast surgery. A radiation dose of 50.4 Gy was delivered with tangential photon fields on the whole breast or chest wall. A single anterior oblique photon field for supraclavicular (SCL) nodes was added if indicated. Serial follow-up chest radiographs were reviewed by a chest radiologist. Radiation Therapy Oncology Group (RTOG) toxicity criteria were used for grading SRP and a modified World Health Organization (WHO) grading system was used to evaluate RPT. The overall percentage of the ipsilateral lung volume that received ${\geq}15\;Gy\;(V_{15}),\;20\;Gy\;(V_{20})$, and $30\;Gy\;(V_{30})$ and the mean lung dose (MLD) were calculated. We divided the ipsilateral lung into two territories, and defined separate DVH parameters, i.e., $V_{15\;TNGT},\;V_{20\;TNGT},\;V_{30\;TNGT},\;MLD_{TNGT}$, and $V_{15\;SCL},\;V_{20\;SCL},\;V_{30SCL},\;MLD_{SCL}$ to assess the relationship between these parameters and RPT. $\underline{Results}$: Four patients (2.1%) developed SRP (three with grade 3 and one with grade 2, respectively). There was no significant association of SRP with clinical parameters such as, age, pre-existing lung disease, smoking, chemotherapy, hormonal therapy and regional RT. When 137 patients treated with 3D-RTP were evaluated, 13.9% developed RPT in the tangent (TNGT) territory and 49.2% of 59 patients with regional RT developed RPT in the SCL territory. Regional RT (p<0.001) and age (p=0.039) was significantly correlated with RPT. All DVH parameters except for $V_{15\;TNGT}$ showed a significant correlation with RPT (p<0.05). $MLD_{TNGT}$ was a better predictor for RPT for the TNGT territory than $V_{15\;SCL}$ for the SCL territory. $\underline{Conclusion}$: The incidence of SRP was acceptable with the RT technique that was used. Age and regional RT were significant factors to predict RPT. The DVH parameter was good predictor for RPT for the SCL territory while $MLD_{TNGT}$ was a better predictor for RPT for the TNGT territory.
Keywords
Breast cancer; Radiotherapy; Pulmonary toxicity; Three-dimensional radiotherapy planning;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Overgaard M, Jensen MS, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Group DBCG 82c randomised trial. Lancet 1999;358: 1641-1648   DOI   ScienceOn
2 Lingos TI. Recht A Vicini F, et al. Radiation pneumonitis in breast cancer treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991:21: 355-360   DOI   ScienceOn
3 Gaffney OK. Prows J. Leavitt DO. et al. Electron arc irradiation of the postmastectomy chest wall: clinical results. Radiother Oncol 1997:42:17-24   DOI   ScienceOn
4 Rothwell RI. Kelly SA. Joslin CA. Radiation pneumonitis in patients treated for breast cancer. Radiother Oncol 1985; 4:9-14   DOI   ScienceOn
5 Lind PA. Gagliardi G. Wennberg B. et al. A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol 1997;36:509-515   DOI
6 Bentzen SM. Skoczylas JZ. Overgaard M. et al. Radiotherapy related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996;88:918-922   DOI   ScienceOn
7 Hernando ML. Marks LB. Bentel GC. et al. Radiationinduced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001 ;51 :650-659   DOI   ScienceOn
8 Freyer CJH. Fitzpatrick PJ. Rider WD. et al. Radiation pneumonitis: experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys 1978:4:931-936   DOI   PUBMED   ScienceOn
9 Rothwell RI. Kelly SA. Joslin CA. Radiation pneumonitis in patients treated for breast cancer. Radiother Oncol 1985; 4:9-14   DOI   ScienceOn
10 Taghian AG. Assaad SI. Niemierko A. et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001;93:1806-1811   DOI   ScienceOn
11 Movsas B. Raffin TA. Epstein AH. et al. Pulmonary radiation injury. Chest 1997;111:1061-1076   DOI   ScienceOn
12 Theuws JC. Kwa SL. Wagenaar AC. et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 1998:48:33-43   DOI   ScienceOn
13 Lind PA. Marks LB. Jamieson TA. et al. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue. Cancer 2002;94:2821-2829   DOI   ScienceOn
14 Johansson S, Bjermer L. Franzen L. et al. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 1998:49:41-47   DOI   ScienceOn
15 Koh E, Sun A, Tran TH, et al. Clinical dose-volume histo¬gram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2006;66:223-228   DOI   ScienceOn
16 Gagliardi G, Bjohle J, Lax I. et al. Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 2000:46:373-381   DOI   ScienceOn
17 Mah K. Van Dyk J. Keane T. et al. Acute radiation induced pulmonary damage: a clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1987;13:179-188   DOI   ScienceOn
18 McDonald S. Rubin P. Phillips TL. et al. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints and potential scoring systems. Int J Radiat Oncol Biol Phys 1995;31 :1187-1203   DOI   ScienceOn
19 Taghian AG, Assaad SI. Niemierko A. et al. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? Int J Radiat Oncol Biol Phys 2005;62:386-391   DOI   ScienceOn
20 Lind PA, Marks LB, Hardenbergh PA, et al. Techinical factors associated with radiation pneumonitis after local- regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys 2002;52:137-143   DOI   PUBMED   ScienceOn
21 Armstrong JG. Zelefsky MJ. Leibel SA. et al. Strategy for dose escalation using 3-dimensional confonnal radiation therapy for lung cancer. Ann Oncol 1995;6:693-697   DOI   PUBMED
22 Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-955   DOI   ScienceOn
23 Price A. Jack WJ. Kerr GR. et al. Acute radiation pneumonitis after postmastectomy irradiation: effect of fraction size. Clin Oncol (R Call Radiol) 1990:2:224-229   DOI
24 Kim IA. Choi lB. Kang KM. et al. Concurrent chemoradiation therapy in stage III non-small cell lung cancer. J Korean Soc Ther Rad Oncol 1997;15:27-36
25 Kahan Z, Csenki M, Varga Z, et al. The risk of early and late lung sequele after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007 [In press]
26 Ragaz J. Jackson SM. Le N. et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-962   DOI   ScienceOn
27 Lind PA. Svane G. Gagliardi G. et al. Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999:43:489-496   DOI   ScienceOn
28 Yu TK. Whitman GJ. Thames HD. et al. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiation in breast cancer patients. J Natl Cancer Inst 2004;96:1676-1681   DOI   PUBMED   ScienceOn
29 Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy [see comments]. J Clin Oncol 1994;12: 447-453   DOI
30 Lind PA, Wennberg B, Gagliardi G, et al. ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys 2006;64:765-770   DOI   ScienceOn
31 Bjermer L. Franze'n L. Littbrand B. et al. Effects of smoking and irradiated volume of inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage. Cancer Res 1990;50:2027-2030   PUBMED
32 Lind PA. Wennberg B. Gagliardi G. et al. Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose. Breast Cancer Res Treat 2001; accepted pending revision
33 Burstein HJ, Bellon JR, Galper S, et al. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer. Int J Radiat Oncol Biol Phys 2006;64:493-504
34 Bucholz TA. Austin-Seymour MM. Moe RE. et al. Effect of delay in radiation in combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 1993:26:23-35   DOI   ScienceOn
35 Gagliardi G, Biohle J, Lax I. et al. Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 2000:46:373-381   DOI   ScienceOn
36 Wennberg B. Gargliardi G. Sundbom L. et al. Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys 2002;52:1196-1206   DOI   ScienceOn